Ratings Umicore

Equities

UMI

BE0974320526

Specialty Chemicals

Market Closed - Euronext Bruxelles Other stock markets 19:55:00 18/07/2025 +04			5-day change	1st Jan Change
15.45 ^EUR	-1.02%		+4.60%	+55.20%

07-10	AlphaValue/Baader Europe Revises Umicore Rating, EPS Forecasts on Upgraded FY25 Guidance	MT
07-09	UMICORE : Well positioned for a cleaner future

Summary: Umicore

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
The company presents an interesting fundamental situation from a short-term investment perspective.
The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Highlights: Umicore

Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the past twelve months, EPS forecast has been revised upwards.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses: Umicore

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company does not generate enough profits, which is an alarming weak point.
The group shows a rather high level of debt in proportion to its EBITDA.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings Chart: Umicore

Source: Surperformance

ESG chart: Umicore

Source: MSCI

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Financial estimates revisions (Composite)	Capi.($)
	UMICORE				4.35B
	ECOLAB INC.				76.27B
	GIVAUDAN SA				43.25B
	SIKA AG				40.57B
	FUJIFILM HOLDINGS CORPORATION				24.53B
	EMS-CHEMIE HOLDING AG				18.48B
	SYMRISE AG				14.46B
	NITTO DENKO CORPORATION				13.01B
	SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.				11.13B
	EVONIK INDUSTRIES AG				9.49B
	Average				25.55B
	Weighted average by Cap.

See all sector ratings

Investor (Composite)

Trader (Composite)

ESG MSCI

Financials

Revenue growth

EPS growth

Capital Efficiency (Composite)

Net Margin

Financial Health (Composite)

Valuation

P/E

EV/Revenue

EV/EBITDA

PBR

Dividend Yield

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (4 months)

Analysts' target price evolution (1 year)

Business Predictability

Surprise rates

Analysts' coverage

Analysts' recommendations divergence

Analysts' Target price divergence

Financial estimates divergence

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes